4Sc AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 4Sc AG with three other
miscellaneous service companies in Europe:
IXICO PLC
of the United Kingdom
(2017
sales of £4.11 million [US$5.16 million]
of which 100%
was Pharmaceutical),
Intervacc AB
of Sweden
(48.00 million Swedish Kronor [US$5.28 million]
), and
Bioinvent International AB
which is
also
based in Sweden
(45.01 million Swedish Kronor [US$4.95 million]
of which 100%
was Drug Development).
Sales Analysis.
4Sc AG reported sales of 4.20 million Euro (US$4.76 million)
for the
year ending
December of 2017.
This
represents
an
increase of 103.7%
versus 2016, when the company's sales were 2.06 million Euro.
The sales level in 2017 was fairly close to the level five years ago: in 2012, 4Sc AG had sales
of 4.35 million Euro.